Analyst firms · Raymond James · ZBH

Raymond James ZBH price target and rating history

Zimmer Biomet Holdings Inc. (ZBH) · Health Care

Raymond James rates Zimmer Biomet Holdings Inc. (ZBH) Mkt Perform with a $144 price target, as of its latest action on Jan 6, 2026. It has published 3 rating actions on ZBH since September 2021, including 1 upgrade and 1 downgrade. Across 7 firms with a ZBH price target in the last 12 months, the median target is $100.

Current rating
Mkt Perform
Price target
$144
Median target, all firms
$100
Actions on ZBH
3

Every Raymond James rating on ZBH

How other firms rate ZBH

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Wells FargoOverweight$123Nov 17, 2026
BarclaysEqual Weight$100Oct 7, 2026
UBSBuy$115Jul 28, 2026
BMO Capital MarketsMarket Perform$95Jul 9, 2026
BTIGNeutralMar 23, 2026
William BlairMkt PerformFeb 20, 2026
Goldman SachsSell$93Jan 9, 2026
Raymond JamesMkt PerformJan 6, 2026
Evercore ISIOutperform$210Jan 5, 2026
Robert W. BairdNeutral$100Dec 16, 2025

Questions about Raymond James and ZBH

What is Raymond James's price target for ZBH?
Raymond James's latest stated price target for Zimmer Biomet Holdings Inc. (ZBH) is $144, from its action on Jan 5, 2023.
What is Raymond James's rating on ZBH?
Raymond James rates ZBH Mkt Perform, a neutral rating, as of Jan 6, 2026.
When did Raymond James last change its view on ZBH?
On Jan 6, 2026, Raymond James downgrades to Mkt Perform from Outperform.
How does Raymond James's ZBH target compare with other analysts?
Across 7 firms with a ZBH price target in the last 12 months, the median target is $100.

More ZBH rating histories

All Raymond James ratingsZBH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.